T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Willdan Group
WLDN
$1.29B
| $395K | ﹤0.01% |
10,359
+626
| +6% | +$26.9K |
|
|
ACR
2377
ACRES Commercial Realty
ACR
$101M
| $394K | ﹤0.01% |
24,390
| – | – |
|
2378
Omeros
OMER
$1.26B
| $392K | ﹤0.01% |
39,582
+4,401
| +13% | +$30.2K |
|
2379
Covenant Logistics
CVLG
$865M
| $391K | ﹤0.01% |
14,328
+934
| +7% | +$25.7K |
|
2380
Cogent Biosciences
COGT
$6.76B
| $388K | ﹤0.01% |
49,643
+5,486
| +12% | +$54.7K |
|
|
DX
2381
Dynex Capital
DX
$3.23B
| $387K | ﹤0.01% |
30,572
+6,015
| +24% | +$75K |
|
2382
Maravai LifeSciences
MRVI
$861M
| $387K | ﹤0.01% |
70,828
+7,946
| +13% | +$51.1K |
|
|
AVDL
2383
DELISTED
Avadel Pharmaceuticals
AVDL
| $386K | ﹤0.01% |
36,673
+6,445
| +21% | +$78.3K |
|
2384
Levi Strauss
LEVI
$8.64B
| $386K | ﹤0.01% |
22,302
| – | – |
|
2385
Driven Brands
DRVN
$2.05B
| $384K | ﹤0.01% |
23,760
+3,952
| +20% | +$62K |
|
|
CHCT
2386
Community Healthcare Trust
CHCT
$430M
| $383K | ﹤0.01% |
19,936
+1,751
| +10% | +$31.7K |
|
|
DENN
2387
DELISTED
Denny's
DENN
| $383K | ﹤0.01% |
63,166
+2,408
| +4% | +$15.3K |
|
2388
Alphatec Holdings
ATEC
$1.49B
| $380K | ﹤0.01% |
41,312
+7,770
| +23% | +$62K |
|
2389
Bank First Corp
BFC
$1.74B
| $379K | ﹤0.01% |
3,824
+611
| +19% | +$60.4K |
|
2390
Shutterstock
SSTK
$217M
| $379K | ﹤0.01% |
12,455
+1,462
| +13% | +$45.9K |
|
2391
Teekay Tankers
TNK
$2.81B
| $379K | ﹤0.01% |
9,524
+1,674
| +21% | +$77.5K |
|
2392
Transcat
TRNS
$888M
| $378K | ﹤0.01% |
3,567
+559
| +19% | +$62K |
|
2393
Vanguard Dividend Appreciation ETF
VIG
$115B
| $378K | ﹤0.01% |
1,928
| – | – |
|
2394
FuboTV Inc
FUBO
$293M
| $376K | ﹤0.01% |
24,840
+4,000
| +19% | +$73.3K |
|
2395
Energy Fuels
UUUU
$3.64B
| $376K | ﹤0.01% |
73,178
+12,037
| +20% | +$74.5K |
|
2396
HCI Group
HCI
$2.28B
| $375K | ﹤0.01% |
3,215
+531
| +20% | +$60.5K |
|
2397
Manitowoc
MTW
$727M
| $375K | ﹤0.01% |
41,070
-13,489
| -25% | -$133K |
|
2398
TechTarget
TTGT
$265M
| $373K | ﹤0.01% |
18,809
+6,126
| +48% | +$162K |
|
2399
Phibro Animal Health
PAHC
$1.37B
| $372K | ﹤0.01% |
17,668
+1,565
| +10% | +$36.2K |
|
2400
Nu Skin
NUS
$236M
| $371K | ﹤0.01% |
53,711
+2,702
| +5% | +$18.6K |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.